Prophylactic Catheter Ablation for the Prevention of Defibrillator Therapy
Open accessThe DOI matches its Crossref record; 28 of the 28 references it cites were found in a registry or an index.
Abstract
BACKGROUND: For patients who have a ventricular tachyarrhythmic event, implantable cardioverter-defibrillators (ICDs) are a mainstay of therapy to prevent sudden death. However, ICD shocks are painful, can result in clinical depression, and do not offer complete protection against death from arrhythmia. We designed this randomized trial to examine whether prophylactic radiofrequency catheter ablation of arrhythmogenic ventricular tissue would reduce the incidence of ICD therapy. METHODS: Eligible patients with a history of a myocardial infarction underwent defibrillator implantation for spontaneous ventricular tachycardia or fibrillation. The patients did not receive antiarrhythmic drugs. Patients were randomly assigned to defibrillator implantation alone or defibrillator implantation with adjunctive catheter ablation (64 patients in each group). Ablation was performed with the use of a substrate-based approach in which the myocardial scar is mapped and ablated while the heart remains predominantly in sinus rhythm. The primary end point was survival free from any appropriate ICD therapy. RESULTS: The mortality rate 30 days after ablation was zero, and there were no significant changes in ventricular function or functional class during the mean (+/-SD) follow-up period of 22.5+/-5.5 months. Twenty-one patients assigned to defibrillator implantation alone (33%) and eight patients assigned to defibrillator implantation plus ablation (12%) received appropriate ICD therapy (antitachycardia pacing or shocks) (hazard ratio in the ablation group, 0.35; 95% confidence interval, 0.15 to 0.78, P=0.007). Among these patients, 20 in the control group (31%) and 6 in the ablation group (9%) received shocks (P=0.003). Mortality was not increased in the group assigned to ablation as compared with the control group (9% vs. 17%, P=0.29). CONCLUSIONS: In this randomized trial, prophylactic substrate-based catheter ablation reduced the incidence of ICD therapy in patients with a history of myocardial infarction who received ICDs for the secondary prevention of sudden death. (Current Controlled Trials number, ISRCTN62488166 [controlled-trials.com].).
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“In the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASH-VT) trial, 30 which randomly assigned 128 ICD patients with a history of ventricular arrhythmia and myocardial infarction to ablation or usual care, arrhythmia recurrence was significantly decreased from 33% to 12% with ablation.”
From Managing with pacemakers and implantable cardioverter defibrillators (2013) · cites this paper as [30]
Citations
Cites
(1997) · New England Journal of Medicine · doi:10.1056/nejm199711273372202 · Cited by 3,232
Prophylactic use of an implantable cardioverter-defibrillator after acute myocardial infarction
Hohnloser, S. H., Kuck, K. H., Dorian, P., Roberts, R. S., Hampton, J. R., Hatala, R., Fain, E., Gent, M., & Connolly, S. J. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa041489 · Cited by 1,519
Marchlinski, F. E., Callans, D. J., Gottlieb, C. D., & Zado, E. (2000) · Circulation · doi:10.1161/01.cir.101.11.1288 · Cited by 1,220
Moss, A. J., Greenberg, H., Case, R. B., Zareba, W., Hall, W. J., Brown, M. W., Daubert, J. P., McNitt, S., Andrews, M. L., & Elkin, A. D. (2004) · Circulation · doi:10.1161/01.cir.0000150390.04704.b7 · Cited by 597
Prevention of Implantable-Defibrillator Shocks by Treatment with Sotalol
Pacifico, A., Hohnloser, S. H., Williams, J. H., Tao, B., Saksena, S., Henry, P. D., & Prystowsky, E. N. (1999) · New England Journal of Medicine · doi:10.1056/nejm199906173402402 · Cited by 422
Guiraudon, G., Fontaine, G., Frank, R., Escande, G., Etievent, P., & Cabrol, C. (1978) · The Annals of Thoracic Surgery · doi:10.1016/s0003-4975(10)62923-2 · Cited by 404
Electrical storm in patients with transvenous implantable cardioverter-defibrillators
Credner, S. C., Klingenheben, T., Mauss, O., Sticherling, C., & Hohnloser, S. H. (1998) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(98)00495-1 · Cited by 376
Arenal, A., Glez-Torrecilla, E., Ortiz, M., Villacastín, J., Fdez-Portales, J., Sousa, E., del Castillo, S., Perez de Isla, L., Jimenez, J., & Almendral, J. (2003) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(02)02623-2 · Cited by 343
Implantable Cardioverter-Defibrillators: Expanding Indications and Technologies
Goldberger, Z., & Lampert, R. (2006) · JAMA · doi:10.1001/jama.295.7.809 · Cited by 271
Research works printed but not linked: 1
- Stevenson WG, 2005, Curr Opin Cardiol, 20, 42
Cited by
Items 601–700 of 964
Leftheriotis, D. I., Flevari, P., Papathanasiou, K. A., Karamanolis, E., Gkatzia, A., Polykandrioti, M., & Filippatos, G. (2025) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.16636 · Cited by 3
Sood, A., Turnbull, S., Silva, K. D., Bhaskaran, A., Bennett, R. G., Campbell, T. G., Thomas, L., & Kumar, S. (2025) · Journal of Arrhythmia · doi:10.1002/joa3.70042 · Cited by 3
Use of Implantable cardioverter-defibrillators
Aronow, W. S. (2010) · Future Cardiology · doi:10.2217/fca.10.99 · Cited by 3
The future of implantable defibrillator and cardiac resynchronization therapy trials
Saksena, S. V., & Nagarakanti, R. (2008) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-008-9302-6 · Cited by 3
“In the recently completed Substrate Mapping & Ablation in Sinus Rhythm to Halt Ventricular Tachycardia (SMASHVT) study, a marked reduction in ventricular tachyarrhythmic events was noted when prophylactic ventricular tachycardia ablation was performed when compared with patients in whom that procedure was not performe…”
ResultBradfield, J. S., Tung, R. H., Boyle, N. G., & Shivkumar, K. (2011) · Heart Failure Reviews · doi:10.1007/s10741-011-9241-7 · Cited by 3
“Recent studies showing improved clinical efficacy (up to 75% success at 1 year) and acceptable complication rates given the high-risk substrate, include the Multicenter Thermocool Ventricular Ablation trial [41] and the Substrate Mapping and Ablation in Sinus Rhythm to Halt Ventricular Tachycardia trial (SMASH VT) [42…”
BackgroundVentricular Tachycardia Ablation as First Line Therapy: Are We There Yet?
Biase, L. D., Santangeli, P., Burkhardt, J. D., & Natale, A. (2013) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12107 · Cited by 3
Hybrid Techniques and Neuraxial Modulation for Treatment of Ventricular Tachycardia
Bourke, T., Mathuria, N. S., Michowitz, Y., & Shivkumar, K. (2011) · Future Cardiology · doi:10.2217/fca.11.15 · Cited by 3
Szumowski, Ł. J., Przybylski, A., Maciąg, A., Derejko, P., Bodalski, R., Zakrzewska, J., Orczykowski, M., Szufladowicz, E., Szwed, H., & Walczak, F. (2009) · PubMed · Cited by 3
The burden of inappropriate shocks in young people and how to avoid them
Upadhyay, G. A., Mela, T., & Singh, J. P. (2012) · Heart · doi:10.1136/heartjnl-2012-301861 · Cited by 3
Troubleshooting of Implantable Cardioverter-Defibrillators
Epstein, A. E., & Riley, M. P. (2011) · Elsevier eBooks · doi:10.1016/b978-1-4377-1616-0.00030-8 · Cited by 3
Does Sotalol Still Have a Role in the Management of Arrhythmias?
Bandaralage, S. P. S., Nirthanan, S., & Niranjan, S. (2016) · American Journal of Therapeutics · doi:10.1097/mjt.0000000000000507 · Cited by 3
A Questionable Indication For ICD Extraction After Successful VT Ablation.
Segreti, L., Cori, A. D., Zucchelli, G., Soldati, E., Coluccia, G., Viani, S. M., Paperini, L., & Bongiorni, M. G. (2015) · Europe PMC (PubMed Central) · doi:10.4022/jafib.1172 · Cited by 3
Jacobson, J. T., Iwai, S., & Aronow, W. S. (2017) · Heart Failure Clinics · doi:10.1016/j.hfc.2017.02.015 · Cited by 3
Hutchinson, M. D., & Garza, H.-H. K. (2018) · Current Treatment Options in Cardiovascular Medicine · doi:10.1007/s11936-018-0610-6 · Cited by 3
Electrical manipulation of the failing heart
Zacà, V., Murphy, T. M., & Biffi, M. (2018) · Heart Failure Reviews · doi:10.1007/s10741-018-9732-x · Cited by 3
Ventrikuläre Herzrhythmusstörungen
Duncker, D., Bauersachs, J. K., & Veltmann, C. (2017) · Der Internist · doi:10.1007/s00108-017-0341-x · Cited by 3
Ventricular Tachycardia and Heart Failure
Altay, H. (2019) · IntechOpen eBooks · doi:10.5772/intechopen.85256 · Cited by 3
Role of catheter ablation in patients with ischemic ventricular tachycardia
Chang, T., Lin, C., Chung, F., Lin, Y., Chang, S., Lo, L., Hu, Y., & Chen, S. (2019) · Journal of the Chinese Medical Association · doi:10.1097/jcma.0000000000000137 · Cited by 3
“37,38 However, the Substrate Modification Study (SMS) trial failed to demonstrate that catheter ablation could prolong the time to first VT/VF recurrence, but could reduce the total number of ICD interventions (>50%).”
da Silva, G. L., Cortez‐Dias, N., Carpinteiro, L. M. R. D. S., Pinto, F. J., & de Sousa, J. (2022) · Revista Portuguesa de Cardiologia · doi:10.1016/j.repc.2021.02.026 · Cited by 4
Which therapy for which condition?
Gersh, B. J., & Opie, L. H. (2013) · Elsevier eBooks · doi:10.1016/b978-1-4557-3322-4.00021-1 · Cited by 3
GENE AND CELL THERAPY FOR LIFE-THREATENING CARDIAC ARRHYTHMIAS.
Rosen, M. R., Danilo, P., & Robinson, R. B. (2009) · PubMed · Cited by 3
Improving Our Understanding of Epicardial Ventricular Tachycardia in Nonischemic Cardiomyopathy
Shivkumar, K., & Tung, R. H. (2009) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2009.05.033 · Cited by 3
Complex problems require complex solutions … but may result in other complex problems
Modi, S. S., & Skanes, A. C. (2011) · Heart Rhythm · doi:10.1016/j.hrthm.2011.06.015 · Cited by 3
Ranolazine in Patients With Implantable Cardioverter-Defibrillators
Albert, C. M. (2018) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.06.008 · Cited by 3
“In comparison, amiodarone plus a beta-blocker was associated with a significant 70% reduction in risk of appropriate ICD shocks in the OPTIC (Optimal Pharmacological Therapy in Cardioverter Defibrillator Patients) trial (17), and in experienced centers, VT ablation for scar-related VT has been associated with 65% to 7…”
BackgroundCatheter Ablation of Ventricular Tachycardia
Marchlinski, F. E., Santangeli, P., & Frankel, D. S. (2020) · Circulation · doi:10.1161/circulationaha.119.045243 · Cited by 3
Actualización en cardiología geriátrica
Martínez‐Sellés, M., López‐Palop, R., Datino, T., & Bañuelos, C. (2009) · Revista Española de Cardiología · doi:10.1016/s0300-8932(09)70041-7 · Cited by 3
Can Early Ablation of Ventricular Tachycardia Improve Survival?
Kanagasundram, A. N., Richardson, T. D., & Stevenson, W. G. (2022) · Circulation · doi:10.1161/circulationaha.122.059730 · Cited by 3
Decompensated Heart Failure With Ventricular Arrhythmia: How Useful Is VT Ablation?
Dimitropoulos, G., Leventogiannis, G., & de Bono, J. P. (2018) · Current Heart Failure Reports · doi:10.1007/s11897-018-0395-7 · Cited by 2
González‐Torrecilla, E., Arenal, Á., Atienza, F., Datino, T., Eídelman, G., Miracle, A. L., Hernández, J., Ávila, P., & Fernández‐Avilés, F. (2012) · Reviews on Recent Clinical Trials · doi:10.2174/157488712802281385 · Cited by 3
The Role of Ventricular Tachycardia Ablation in the Reduction of Implantable Defibrillator Shocks
Venkataraman, G., & Strickberger, S. A. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.12.006 · Cited by 2
Current practice and recent advances in catheter ablation
Lee, J., Bugden, H., & Grace, A. A. (2013) · British Journal of Cardiac Nursing · doi:10.12968/bjca.2013.8.6.273 · Cited by 2
Treatment of ventricular tachycardia: consider ablation sooner
Bloom, H. L. (2009) · F1000 Medicine Reports · doi:10.3410/m1-71 · Cited by 2
Rashid, A., Khan, M. F. J., & Rashid, J. (2024) · Cureus · doi:10.7759/cureus.67649 · Cited by 3
“Randomized trials have estimated that CA for VT lowers the recurrence rate [7,8], and multicenter observational studies have linked a higher survival rate to the absence of VT following CA [14].”
BackgroundWang, M., Goldenberg, I., Younis, A., Goldenberg, I., Christof, M., Huang, D. T.-C., McNitt, S. A., Polonsky, B., Kutyifa, V., Zaręba, W., et al. (2024) · Heart Rhythm · doi:10.1016/j.hrthm.2024.11.033 · Cited by 2
The Timing for Primary Prevention for ICD in the Current Era of Pharmacotherapy
Shchendrygina, A., Yehya, A., & Skouri, H. N. (2025) · Cardiac failure review · doi:10.15420/cfr.2025.05 · Cited by 2
“48,49 It is also worth noting that ICD therapy is associated with several adverse events, including device infections, lead displacement and lead-induced tricuspid regurgitation deterioration, which occur in approximately 1.5%, 3.1%, and 9.4% of cases, respectively.”
InfluentialElbenawi, H., Ayman, Y., Hashim, A., Agarwal, S., Wagdy, M., Hamed, B. M., Thakurathi, P., Al‐Shammari, A. S., Mohamed, K. A., Kalaiger, A. M., et al. (2025) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70075 · Cited by 2
Ranganathan, D., Mills, M. T., Ramalingam, V., Vázquez‐Calvo, S., Quaiattini, A., Joza, J. E., Essebag, V., & Verma, A. (2026) · EP Europace · doi:10.1093/europace/euaf272 · Cited by 2
Façanha, T. M., Pereira, A. I. G., Garcia, M. F. C., Mendonça, E. T., Ramos, J. V. J., & Mesquita, L. A. (2026) · EP Europace · doi:10.1093/europace/euag073 · Cited by 2
Update Ablation ventrikulärer Tachyarrhythmien
Mathew, S., Müller, P., Hardy, C. A., Scanavacca, M., & Deneke, T. (2022) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-022-00840-4 · Cited by 2
“und die VT-freie Zeit verlängern kann [11, 12].”
The Current Landscape of Ventricular Tachycardia Trials: A Systematic Review of Registered Studies
Gupta, A., Danaila, V., Silva, K. D., Bhaskaran, A., Turnbull, S., Wong, M. S., Campbell, T. G., & Kumar, S. (2024) · Heart Lung and Circulation · doi:10.1016/j.hlc.2024.01.041 · Cited by 2
Safety and efficacy of same-day discharge for premature ventricular complex ablations
Padanilam, M. S., Patel, P. J., Joshi, S. A., Nair, G. V., Clark, B. A., Shah, A. N., Field, J., Prystowsky, E. N., & Gilge, J. L. (2024) · EP Europace · doi:10.1093/europace/euae205 · Cited by 2
Characterization of the Thermal Properties of Healthy vs Infarcted Ventricular Tissue
Izquierdo, M., Pérez, J. J., Gaona, O., Navarro, J., Navarrete‐Navarro, J., Martínez‐Dolz, L., Almenar, L., Cano, Ó., Mancheño, N., González‐Suárez, A., et al. (2025) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2025.02.032 · Cited by 2
New Ways to Avoid Unnecessary and Inappropriate Shocks
Toquero, J., Castro, V., Mitroi, C. D., & Fernandez, I. (2011) · InTech eBooks · doi:10.5772/24181 · Cited by 2
Das, M. K., Rajdev, A., & Kalra, V. (2014) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2014.05.002 · Cited by 2
The Year in Imaging Related to Electrophysiology
Tops, L. F., & Bax, J. J. (2009) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2008.12.023 · Cited by 2
Approach to Arrhythmia in Heart Failure
Gaïta, F., Anselmino, M., & Matta, M. (2016) · Springer eBooks · doi:10.1007/978-3-319-45237-1_12 · Cited by 2
Ablation outperforming antiarrhythmic drugs need for more research
Sossalla, S. T. (2017) · Cardiovascular Research · doi:10.1093/cvr/cvx037 · Cited by 2
“SMASH-VT trial).(2) However, as a limitation in these trials, control patients were not adequately treated with escalation of pharmacological antiarrhythmic drugs.”
BackgroundBáez-Escudero, J. L. (2017) · Elsevier eBooks · doi:10.1016/b978-0-323-47870-0.00037-4 · Cited by 2
Substrate Ablation of Post-infarction Ventricular Tachycardias
Ávila, P., & Arenal, Á. (2014) · Revista Española de Cardiología (English Edition) · doi:10.1016/j.rec.2013.08.019 · Cited by 2
“The ablation of CSC and EIC/LP related to clinical or induced VT has been shown to significantly reduce the rate of recurrence of ventricular arrhythmias and to lower the risk of receiving ICD shocks.(8,19,22) On the basis of these data, to simplify the procedure and treat patients showing no electrocardiographic evid…”
BackgroundEpicardial Ablation of Ischemic Ventricular Tachycardia
Tedrow, U. B., & Stevenson, W. G. (2010) · Cardiac Electrophysiology Clinics · doi:10.1016/j.ccep.2009.11.005 · Cited by 2
Grenzen und Möglichkeiten der invasiven Risikostratifikation
Rolf, S., & Haverkamp, W. (2009) · Herz · doi:10.1007/s00059-009-3294-6 · Cited by 2
Secondary Prevention in Heart Failure
Robinson, M., Epstein, A. E., & Callans, D. J. (2011) · Heart Failure Clinics · doi:10.1016/j.hfc.2010.12.002 · Cited by 2
Jiménez‐Candil, J., Morinigo, J., Hernández, J., Martín‐Garcia, A., Duran, Ö., RAMA, J. C., Ledesma, C., & Sanchez, P. L. (2014) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12451 · Cited by 2
Prognostic Significance of Implantable Defibrillator Shock: Are All Shocks Created Equal?
FREEDBERG, N. A., & Feldman, A. Z. (2012) · Journal of Cardiovascular Electrophysiology · doi:10.1111/j.1540-8167.2012.02299.x · Cited by 2
Kumar, S., & Tedrow, U. B. (2016) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.12921 · Cited by 2
Implantable Cardioverter-Defibrillator Programming and Troubleshooting
Riley, M. P., & Epstein, A. E. (2016) · Elsevier eBooks · doi:10.1016/b978-0-323-37804-8.00038-9 · Cited by 3
Katheterablation ventrikulärer Extrasystolen und Kammertachykardien im hohen Alter
Halbfaß, P., Nentwich, K., Sonne, K., Ene, E., Fochler, F., Mügge, A., Schieffer, B., & Deneke, T. (2017) · Herzschrittmachertherapie + Elektrophysiologie · doi:10.1007/s00399-017-0483-5 · Cited by 2
Ventricular Arrhythmias and Heart Failure
Ellis, E. R., & Josephson, M. E. (2017) · Springer eBooks · doi:10.1007/978-1-4471-4219-5_15 · Cited by 2
Self-citationSpera, F. R., & Sarkozy, A. (2020) · Current Cardiovascular Risk Reports · doi:10.1007/s12170-020-0638-5 · Cited by 2
Empfehlung der Deutschen Gesellschaft für Kardiologie zur Katheterablation ventrikulärer Arrhythmien
Deneke, T., BOSCH, R. F., Deisenhofer, I., Eckardt, L., Schmidt, B., & Sommer, P. (2021) · Der Kardiologe · doi:10.1007/s12181-020-00440-x · Cited by 2
Ablative radiosurgery for cardiac arrhythmias – A systematic review
Munshi, A. (2021) · Cancer/Radiothérapie · doi:10.1016/j.canrad.2021.01.009 · Cited by 2
Tachykarde Rhythmusstörungen: Welches Herzrasen ist wie kritisch?
Reißmann, B., Rottner, L., Rillig, A., & Metzner, A. (2021) · MMW - Fortschritte der Medizin · doi:10.1007/s15006-021-9651-y · Cited by 2
Kitamura, Τ., Fukamizu, S., Arai, T., Kawajiri, K., Tanabe, S., Tokioka, S., Inagaki, D., & Hojo, R. (2021) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-021-01037-4 · Cited by 2
“Several studies have demonstrated the efficacy of radiofrequency catheter ablation as an adjunctive therapy for selected patients with structural heart disease (SHD) and drug-resistant ventricular tachycardia (VT) [1, 2].”
BackgroundKakarla, J., Benson, C., Abbas, M., Begg, G. A., Twomey, D. J., Thornley, A. R., Bates, M. G. D., Ahmad, M., Arif, H. A., Banerjee, A., et al. (2021) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd014733 · Cited by 2
Catheter Ablation at the Forefront: The Tribulations of Clinical Trials
Bradfield, J. S., & Tung, R. H. (2016) · Journal of Innovations in Cardiac Rhythm Management · doi:10.19102/icrm.2016.070103 · Cited by 2
Lampropoulou, E., Kouraki, K., Strauss, M., Mohammad, O., Zahn, R., & Kleemann, T. (2023) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.15906 · Cited by 2
“Several ablation trials have been able to reduce the recurrence of ventricular arrhythmias but not the mortality rate.(7) Triggers such as ischemia, electrolyte imbalances, or strong emotions may induce ventricular tachyarrhythmias(8,9) and could be a target for therapy.”
BackgroundMüller, J., Chakarov, I., Nentwich, K., Berkovitz, A., Barth, S., Ausbuettel, F., Waechter, C., Lehrmann, H., & Deneke, T. (2024) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-024-01883-y · Cited by 2
Results of Recent Studies in Catheter Ablation of Ventricular Tachycardias
Arya, A., Piorkowski, C., Kircher, S., Sommer, P., Bollmann, A., Gaspar, T., & Hindricks, G. (2009) · Herz · doi:10.1007/s00059-009-3298-2 · Cited by 2
The paradox of ICD shocks: Sudden cardiac death prevention—Heart failure death acceleration
Bradfield, J. S., & Boyle, N. G. (2010) · Heart Rhythm · doi:10.1016/j.hrthm.2009.12.028 · Cited by 2
Heart Failure and Sudden Death
Cha, Y., & Shen, W.-K. (2013) · Springer eBooks · doi:10.1007/978-1-4471-4978-1_25 · Cited by 2
Wißner, E., & Kück, K. (2014) · European Heart Journal · doi:10.1093/eurheartj/eht559 · Cited by 2
CMR for Mapping the Missing Dimension in Ventricular Tachycardia Ablation
Nazarian, S. (2010) · JACC. Cardiovascular imaging · doi:10.1016/j.jcmg.2009.11.007 · Cited by 2
Catheter Ablation in Patients with ICDs
Kanagaratnam, P., Koa‐Wing, M., & Peters, N. S. (2008) · New England Journal of Medicine · doi:10.1056/nejmc080125 · Cited by 2
Recurrent Ventricular Tachycardia — More Drugs or Bring Out the Catheter?
CAIN, M. E., & Curtis, A. B. (2016) · New England Journal of Medicine · doi:10.1056/nejme1606305 · Cited by 2
Aleong, R. G., & Sauer, W. H. (2017) · Journal of the American Heart Association · doi:10.1161/jaha.117.007087 · Cited by 2
“Disease) suggested that an early, even prophylactic, ablation strategy decreased future ventricular arrhythmias.(5,6) More recent data show that successful ablation for ventricular tachycardia is associated with improved survival compared with unsuccessful ablation.”
BackgroundVentricular Tachycardia Ablation
Sapp, J. L., & Deyell, M. W. (2017) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2017.08.004 · Cited by 2
To Reach or Not to Reach the Whole Arrhythmic Substrate?
Berruezo, A., & Acosta, J. (2019) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2018.09.003 · Cited by 2
“V entricular tachycardia (VT) substrate ablation is an effective therapeutic alternative for patients with recurrent episodes of scardependent VT (1).”
BackgroundNguyen, D. T., & Baykaner, T. (2020) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2020.03.009 · Cited by 2
Electrophysiologic mapping and cardiac ablation therapy for prevention of ventricular tachycardia
AbdelWahab, A. M., & Sapp, J. L. (2020) · Elsevier eBooks · doi:10.1016/b978-0-12-813704-8.00031-0 · Cited by 2
Nakasone, K., Fukuzawa, K., Kiuchi, K., Takami, M., Sakai, J., Nakamura, T., Yatomi, A., Sonoda, Y., Takahara, H., Yamamoto, K., et al. (2022) · Journal of Arrhythmia · doi:10.1002/joa3.12796 · Cited by 1
Nentwich, K., Klingel, K., Ene, E., Müller, J., Berkowitz, A., Barth, S., & Deneke, T. (2024) · Clinical Research in Cardiology · doi:10.1007/s00392-024-02509-z · Cited by 1
Hwang, C., Kuzmin, G. A., Maher, T., & Aghdam, N. (2025) · Cureus · doi:10.7759/cureus.87275 · Cited by 1
Kaestner, L., Xie, J., Fanslau, H., Siebenlist, K., Eckl, M., Oppitz, H., Fleckenstein, J., Buergy, D., Kuru, M., Kuschyk, J., et al. (2025) · Physics and Imaging in Radiation Oncology · doi:10.1016/j.phro.2025.100827 · Cited by 1
“Radiofrequency catheter ablation is the gold standard for symptomatic ventricular tachycardia, reducing both symptoms and mortality [6,7].”
Amanatova, V. A., Khachirov, M. R., Uskach, T. M., Фаресовна, А. Д., Vereshchagina, A. V., Podianov, M., Cherkashin, D. I., Grishin, I. R., & Валерьевич, С. О. (2025) · Journal of Arrhythmology · doi:10.35336/va-1479 · Cited by 1
Ventricular tachycardia ablation in ischaemic cardiomyopathy: who, when and how?
Hadjis, A. E., Marco, C. D., Raymond, J., & Sapp, J. L. (2025) · Heart · doi:10.1136/heartjnl-2024-325370 · Cited by 1
“17 Notably, the trial did not evaluate the efficacy of AADs and was not powered to detect a difference in mortality.”
InfluentialPeriprocedural Outcomes of VT Ablation in Ischemic Compared to Non‐Ischemic Dilated Cardiomyopathy
Duhan, S., Ali, S., Alsaeed, T., Kumar, M., Keisham, B., Mehta, S. S., Adoni, N. A., Mongwa, M., Rhee, B. J., & Garg, A. (2025) · Annals of Noninvasive Electrocardiology · doi:10.1111/anec.70126 · Cited by 1
Long-term outcomes of ventricular tachycardia ablation in patients presenting with electrical storm
Pereira, J. C., Sousa, R. B., Gomes, D., Matos, D. N., Rodrigues, G., Carmo, J., Santos, P. G., Carmo, P., Costa, F. M., Cavaco, D., et al. (2025) · International Journal of Cardiology · doi:10.1016/j.ijcard.2025.134015 · Cited by 1
Amir, M., Hassan, A. A. K., Ali, E. F., Noor, M., Nazir, A., Kamran, M., Rizwan, A., Fahim, M. A., Usman, M., Awais, M. N., et al. (2026) · Medicine · doi:10.1097/md.0000000000047261 · Cited by 1
“[20] VTACH, a multicenter randomized open trial, recruited patients with a stable VT, myocardial infarction and reduced left ventricular ejection fraction.”
Impact of catheter ablation on prognostic outcomes in electrical storm
Moersdorf, M., Sohns, C., Sciacca, V., Guckel, D., Beyer, S. E., Hamriti, M. E., Winnik, S. H., Khalaph, M., Braun, M., Didenko, M., et al. (2026) · Clinical Research in Cardiology · doi:10.1007/s00392-026-02846-1 · Cited by 1
Psychological trauma and health-related quality of life following ventricular tachycardia ablation
Bilanovic, A., Irvine, J. F., Porta‐Sánchez, A., King, B., Angaran, P., Dorian, P., Baskaran, A., Nayyar, S., Ezzat, V., Sawhney, V., et al. (2026) · Journal of Interventional Cardiac Electrophysiology · doi:10.1007/s10840-025-02211-8 · Cited by 2
Dulal, D., Maraey, A. M., Chacko, P., Dhanjal, T., Maan, A., & Heist, E. K. (2026) · European Heart Journal Open · doi:10.1093/ehjopen/oeag057 · Cited by 1
Preda, A., Guarracini, F., Falasconi, G., Schiavone, M., Latini, A. C., Cersosimo, A., Villaschi, A., Sabatino, M., Falco, R., Luca, L. D., et al. (2026) · Pacing and Clinical Electrophysiology · doi:10.1111/pace.70222 · Cited by 1
Botto, G. L., Migliore, F., Pieragnoli, P., Viani, S. M., Bisignani, A., Ziacchi, M., Silvetti, M. S., Nigro, G., Bianchi, V., Mariani, M. V., et al. (2026) · Heart Rhythm · doi:10.1016/j.hrthm.2026.05.034 · Cited by 1
Turreni, F., Santini, L., Loricchio, M. L., Castro, A. J., Lova, R. M., Bolao, I. G., Solimene, F., Granatelli, A., Giaccardi, M., Colella, A., et al. (2026) · Journal of Cardiovascular Electrophysiology · doi:10.1111/jce.70390 · Cited by 1
Mahmoodi, E., Younis, A., Higuchi, K., Sroubek, J., Lee, J. Z., Chung, R., Dasa, O., Nakhla, S., Paulin, B., Hight, N., et al. (2026) · JACC. Clinical electrophysiology · doi:10.1016/j.jacep.2026.08.028 · Cited by 1
Ablation of Post-Myocardial Infarction Focal Ventricular Tachycardia
Maluski, A., Lațcu, D. G., RICARD, P., & Saoudi, N. C. (2010) · Pacing and Clinical Electrophysiology · doi:10.1111/j.1540-8159.2009.02679.x · Cited by 1
Usefulness of scintigraphy to predict electrical storms in severe idiopathic dilated cardiomyopathy
Takigawa, M., Kiso, K., Noda, T., Kurita, T., Yamada, Y., Okamura, H., Satomi, K., Suyama, K., Aihara, N., Nanasato, M., et al. (2013) · Annals of Nuclear Medicine · doi:10.1007/s12149-013-0699-3 · Cited by 1
“In addition, recent reports revealed the possibility of empirical ablation techniques for substrate modification to prevent or reduce VT/ VF episodes [24, 25].”
BackgroundCardiac arrhythmias and pacing
Liew, R. (2012) · Srce i krvni sudovi · doi:10.5937/siks1204287l · Cited by 1
Infusion Needle Ablation Catheter
Hsia, H. H., & Xiong, N. (2019) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2018.12.069 · Cited by 1
“Multiple studies have demonstrated the efficacy of catheter ablation in reducing VT recurrences (2,3) and its superiority to the use of antiarrhythmic drugs (4).”
BackgroundActive Ventricular Arrhythmias
de Luna, A. B. (2012) · Wiley eBooks · doi:10.1002/9781118392041.ch16 · Cited by 1
Metadata
- Authors
- Reddy, V. Y., Reynolds, M. R., Neuzil, P., Richardson, A. W., Taborsky, M., Jongnarangsin, K., Kralovec, S., Sediva, L., Ruskin, J. N., & Josephson, M. E.
- Affiliations
- Massachusetts General Hospital (US)
- Beth Israel Deaconess Medical Center (US)
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2007-12-27
- Volume
- 357
- Issue
- 26
- Pages
- 2657-2665
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- PMC
- PMC2390777
- OpenAlex
- W2139803224
- Cited by
- 959
- References
- 28
- Citations by year
- 2026: 39 · 2025: 42 · 2024: 47 · 2023: 43 · 2022: 53 · 2021: 45 · 2020: 54 · 2019: 62 · 2018: 53 · 2017: 63 · 2016: 40 · 2015: 59 · 2014: 46 · 2013: 56 · 2012: 48
- FWCI
- 33.47
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Europe PMC (PubMed Central) (acceptedVersion)
- PubMed Central (acceptedVersion)
- Funders
- National Heart, Lung, and Blood Institute (K23 HL 68064, K23HL077171, K23HL068064)
- Topics
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac Arrhythmias and Treatments
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac pacing and defibrillation studies
- Health Sciences › Medicine › Cardiology and Cardiovascular Medicine › Cardiac electrophysiology and arrhythmias
- Keywords
- implantable cardioverter-defibrillator, ventricular tachyarrhythmia, myocardial infarction, sudden cardiac death, radiofrequency ablation, substrate-based ablation, myocardial scar, ICD shocks, secondary prevention
- MeSH terms
- Aged, Electric Countershock, Female, Follow-Up Studies, Humans, Male, Middle Aged, Myocardial Infarction, Prospective Studies, Ventricular Fibrillation, Multivariate Analysis, Death, Sudden, Cardiac, Catheter Ablation, Defibrillators, Implantable, Tachycardia, Ventricular, Kaplan-Meier Estimate
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.